In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomarker Diagnostics: Place Your Bets Wisely

Executive Summary

Biomarker diagnostics are the linchpin of personalized medicine. But building a successful business around such tests is anything but straightforward, given the complexities associated with both their development and commercialization. Today's molecular diagnostic companies need to think carefully before they choose a "go it alone" strategy when developing a particular test. It may make more sense to forge a partnership with another diagnostic company or a drug developer with the goal of sharing costs and relative risks.
Advertisement

Related Content

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q1 2009
How to Earn the Economic Payback Diagnostics Companies Deserve
What New Her2 Tests Say about Personalized Medicine
Biomarkers for Psychiatric Drugs: Outlier or Opportunity?
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q1 2008
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Does Roche Have It Right?
Problems With Biomarkers: A Tale of Three Drugs
GSK and diaDexus' Rx-Dx Partnership Model
Chutzpah: Millennium Takes on Diagnostics

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003014

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel